pO2 reporter composite hydrogel macroencapsulation devices for magnetic resonance imaging oxygen quantification

Author:

Emerson Amy E.1,Sugamura Yuka1,Mazboudi Jad1,Abdallah Tuhfah M.1,Seaton Charmayne D.1,Ghasemi Azin1,Kodibagkar Vikram D.1,Weaver Jessica D.1ORCID

Affiliation:

1. School of Biological and Health Systems Engineering Arizona State University Tempe Arizona USA

Abstract

AbstractHydrogel cell encapsulation devices are a common approach to reduce the need for chronic systemic immunosuppression in allogeneic cell product transplantation. Macroencapsulation approaches are an appealing strategy, as they maximize graft retrievability and cell dosage within a single device; however, macroencapsulation devices face oxygen transport challenges as geometries increase from preclinical to clinical scales. Device design guided by computational approaches can facilitate graft oxygen availability to encapsulated cells in vivo but is limited without accurate measurement of oxygen levels within the transplant site and graft. In this study, we engineer pO2 reporter composite hydrogels (PORCH) to enable spatiotemporal measurement of oxygen tension within macroencapsulation devices using the proton Imaging of siloxanes to map tissue oxygenation levels (PISTOL) magnetic resonance imaging approach. We engineer two methods of incorporating siloxane oximetry reporters within hydrogel devices, an emulsion and microbead‐based approach, and evaluate PORCH cytotoxicity on co‐encapsulated cells and accuracy in quantifying oxygen tension in vitro. We find that both emulsion and microbead PORCH approaches enable accurate in situ oxygen quantification using PISTOL magnetic resonance oximetry, and that the emulsion‐based PORCH approach results in higher spatial resolution.

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

NIH

Publisher

Wiley

Reference44 articles.

1. Insulin expression and C‐peptide in type 1 diabetes subjects implanted with stem cell‐derived pancreatic endoderm cells in an encapsulation device;Shapiro AJ;Cell Rep Med,2021

2. First‐in‐human phase 1/2 clinical trial of SIG‐001, an innovative shielded cell therapy platform, for hemophilia Α;Shapiro AD;Blood,2020

3. Quality cell therapy manufacturing by design

4. Commercial Scale Manufacturing of Allogeneic Cell Therapy

5. From immunosuppression to tolerance

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3